source site Rayno Biopharmaceutical Stocks- Including New Picks
Another great day for biotech with most Rayno stocks in a rally mode with a bit of profit taking on Gilead Sciences(GILD) down 1%. Notable movers up on our core picks are:
Alkermes (ALKS), Amgen (AMGN), Ariad (ARIA), Regeneron (REGN) and Vertex (VRTX).Our top small cap pick http://arthurproductions.com.au/?ded=29 Achillion (ACHN) is up 27% over 5 days and 254% YTD.
A few posts ago we re-iterated FBT as our top core portfolio pick. It is an ETF that is up 6.58% over 5 days and 33% YTD. FBT is a core Rayno holding because it consistently outperforms funds and ETFs, has a large cap weighting, and somehow manages to have the big winners like Biogen Idec BIIB), Intermune (ITMN and Pharmacyclics (PCYC).The market cap of FBT is $1.3B.
On August 11, we recommended investor buy small and mid cap biotech stocks now for a Q4 rally and our new picks were:
order Pregabalin Celldex (CLDX) up 6.14% over 5 days and Karyopharm Therapeutics(KPTI) up 3.4% over 5 days.